Literatur
-
1
Leuschner U, Fischer H, Kurtz W. et al .
Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial.
Gastroenterology.
1989;
97
1268-1274
-
2
Poupon R E, Balkau B, Eschwege E. et al .
A multicenter controlled trial of ursodiol for the treatment of primary biliary cirrhosis.
New Engl J Med.
1991;
324
1548-1554
-
3
Poupon R E, Poupon R, Balkau B. et al .
Ursodiol for the long-term treatment of primary biliary cirrhosis.
N Engl J Med.
1994;
330
1342-1347
-
4
Lindor K D, Therneau T M, Jorgensen R A. et al .
Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis.
Gastroenterology.
1996;
110
1515-1518
-
5
Heathcote E JL, Cauch-Dudeck K, Walker V. et al .
The Canadian multi-center double blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis.
Hepatology.
1994;
19
1149-1156
-
6
Poupon R E, Lindor K D, Cauch-Dudek K. et al .
Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.
Gastroenterology.
1997;
113
884
-
7
Leuschner M, Maier K P, Schlichting J. et al .
Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial.
Gastroenterology.
1999;
117
918-925
-
8
Stiehl A, Walker S, Stiehl L. et al .
Effects of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3 year pilot study with a placebo-controlled study period.
J Hepatol.
1994;
20
57-64
-
9
Beuers U, Spengler U, Kruis W. et al .
Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo controlled trial.
Hepatology.
1992;
16
707-714
-
10
Lindor KD and the Mayo PSC/UDCA study group: Ursodiol for the treatment of primary sclerosing cholangitis.
N Engl J Med.
1997;
336
691-695
-
11
Stiehl A, Rudolph G, Sauer P. et al .
Efficacy of ursodeoxycholic acid and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study.
J Hepatology.
1997;
26
560-566
-
12
Mitchell S A, Bansi D S, Hunt N et al.
A preliminary trial of high dose ursodeoxycholic acid in primary sclerosing cholangitis: Results of a randomized double-blind placebo-controlled study.
Gastroenterology.
2001;
121
900-907
-
13
Harnois D M, Angulo P, Jorgensen R A. et al .
High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis.
Am J Gastroenterol.
2001;
96
1558-1562
-
14
Stiehl A, Rudolph G, Klöters-Plachky P. et al .
Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment.
J Hepatology.
2002;
36
151-156
Prof. Dr. med. Adolf Stiehl
Universitätsklinikum Heidelberg
Bergheimer Straße 58
69115 Heidelberg
